While CHRNA3 is predominantly studied in the context of lung cancer, emerging evidence suggests that it may also be involved in other types of cancer, such as bladder cancer and pancreatic cancer. The mechanisms by which CHRNA3 contributes to these cancers are not fully understood, but it is believed that similar pathways involving cell proliferation and apoptosis are affected.
